Niagen Bioscience NAGE Insider Ownership

Updated Oct 10, 2026

Over the trailing 12 months, NAGE insiders bought $45,616 worth of shares (6.69K shares) in open-market trades, with no open-market sales.

• Among Niagen Bioscience's insiders, the largest open-market purchases in the past 12 months were by Ozan Pamir (Chief Financial Officer), totaling $45,616 (6.69K shares), most recently on November 14, 2025.
• Apart from open-market trades, NAGE insiders received 7.67K shares in stock awards and acquired 20K shares through option exercises and conversions in the past 12 months.
• Business Quant data shows Niagen Bioscience insiders holding 3.5Mn shares in total in their latest Form 4 filings.
• By type of ownership, NAGE insiders hold 37.93% of their shares directly (1.33Mn shares) and 62.07% indirectly (2.17Mn shares).
• Holdings in Niagen Bioscience stock are reported by 5 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
• Niagen Bioscience's three largest insider shareholders, based on their latest Form 4 filings, are Frank L. Jaksch Jr. (Director, 2.32Mn shares), Robert N. Fried (Chief Executive Officer, 1.16Mn shares) and Ozan Pamir (Chief Financial Officer, 13.85K shares).
• The largest insider, Frank L. Jaksch Jr., holds 66.27% of NAGE's insider total.
• Institutions accounted for 40.26% of NAGE's outstanding shares in Q2 2026, insiders about 4.41% per their latest Form 4 filings, and other investors, including the public, about 55.33%.
• Over the trailing 12 months, 10 insiders reported transactions in NAGE stock across 15 Form 4 filings.
• Insider figures for NAGE include Form 4 filings through July 8, 2026.